Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer.
about
Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Elevated expression of a pharm ...... in gastric and breast cancer.
@en
Elevated expression of a pharm ...... in gastric and breast cancer.
@nl
type
label
Elevated expression of a pharm ...... in gastric and breast cancer.
@en
Elevated expression of a pharm ...... in gastric and breast cancer.
@nl
prefLabel
Elevated expression of a pharm ...... in gastric and breast cancer.
@en
Elevated expression of a pharm ...... in gastric and breast cancer.
@nl
P2860
P356
P1433
P1476
Elevated expression of a pharm ...... in gastric and breast cancer.
@en
P2093
Lorenzo Fornaro
Pier-Luc Clermont
P2860
P304
P356
10.2217/EPI-2017-0074
P577
2017-09-06T00:00:00Z